TNFR2 humanized mice: an ideal model for studying anti-TNFR2 antibodies

被引：0
|
作者：
Wang, Huiyi
Li, Ying
Zhang, Mingkun
Su, Xu
Chen, Santi Suryani
Li, Zhiying
Moore, Mark Wade
Zhao, Jing
Gao, Xiang
Ju, Cunxiang
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5201
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Novel TNFR2 humanized mouse model for human TNFR2 antibody evaluation
    Guo, Yanan
    Li, Yanan
    Zhou, Xiaofei
    Su, Youhong
    Lin, Qingcong
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rhabar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise L.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [3] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rahbar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Generation and validation of a novel humanized TNFR2 mouse model for the evaluation of therapeutic TNFR2 antibody.
    Zhao, Xiaofeng
    Pang, Ran
    Liu, Xiaoqing
    Li, Wenjing
    He, Xianfei
    Ouyang, Xuesong
    Cao, Zhuoxiao
    Tang, Renhong
    Yang, Wenqing
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies
    Torrey, Heather
    Butterworth, John
    Mera, Toshiyuki
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Defusco, Audrey
    Plager, Sara
    Warden, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise L.
    CANCER RESEARCH, 2017, 77
  • [6] Dissecting the mechanism of action targeting TNFR2 with a lignd blocking anti-TNFR2 antibody that elicits potent anti-tumor activity.
    Zhao, Xiaofeng
    Liu, Xiaoqing
    Gao, Zhenna
    Wang, Mengyu
    Li, Wenjing
    Pang, Ran
    Yang, Wenqing
    Cao, Zhuoxiao
    Tang, Renhong
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
    Valentina Pegoretti
    Jan Bauer
    Roman Fischer
    Iskra Paro
    Wanda Douwenga
    Roland E. Kontermann
    Klaus Pfizenmaier
    Evelien Houben
    Bieke Broux
    Niels Hellings
    Wia Baron
    Jon D. Laman
    Ulrich L. M. Eisel
    Journal of Neuroinflammation, 20
  • [8] An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering
    Inoue, Masaki
    Tsuji, Yuta
    Kashiwada, Ayaka
    Yokoyama, Asahi
    Iwata, Akane
    Abe, Yasuhiro
    Kamada, Haruhiko
    Tsunoda, Shin-ichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 697
  • [9] Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
    Pegoretti, Valentina
    Bauer, Jan
    Fischer, Roman
    Paro, Iskra
    Douwenga, Wanda
    Kontermann, Roland E.
    Pfizenmaier, Klaus
    Houben, Evelien
    Broux, Bieke
    Hellings, Niels
    Baron, Wia
    Laman, Jon D.
    Eisel, Ulrich L. M.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [10] Anti-TNFR2 VHH Agonistic Antibodies Promote and Stabilize Treg Immunosuppressive Activity
    Swee, Lee Kim
    Knopf, Julia
    Prochnicki, Tomasz
    Koenig, Paul-Albert
    Kirchhoff, Alexander
    Preiss, Laura
    Huber, Ferdinand
    Seifried, Annegrit
    Murawjew, Olga
    Baumann, Fabienne
    Assis, Jessica
    Hennemann, Sonja
    Kolbe, Felix
    Schnell, Helena
    Orlik, Thomas
    Valle, Kevin Blanco
    Telling, Alissa
    Sanchez, Brian
    Opipari, Anthony
    Stuwe, Tobias
    Soisson, Stephen
    Franchi, Luigi
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 110 - 111
12345